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Shank3, a postsynaptic scaffolding protein involved in regulating excitatory synapse
assembly and function, has been implicated in several brain disorders, including autism
spectrum disorders (ASD), Phelan-McDermid syndrome, schizophrenia, intellectual
disability, and mania. Here we generated and characterized a Shank3 knock-in
mouse line carrying the Q321R mutation (Shank3Q321R mice) identified in a human
individual with ASD that affects the ankyrin repeat region (ARR) domain of the Shank3
protein. Homozygous Shank3Q321R/Q321R mice show a selective decrease in the
level of Shank3a, an ARR-containing protein variant, but not other variants. CA1
pyramidal neurons in the Shank3Q321R/Q321R hippocampus show decreased neuronal
excitability but normal excitatory and inhibitory synaptic transmission. Behaviorally,
Shank3Q321R/Q321R mice show moderately enhanced self-grooming and anxiolytic-
like behavior, but normal locomotion, social interaction, and object recognition and
contextual fear memory. In addition, these mice show abnormal electroencephalogram
(EEG) patterns and decreased susceptibility to induced seizures. These results indicate
that the Q321R mutation alters Shank3 protein stability, neuronal excitability, repetitive
and anxiety-like behavior, EEG patterns, and seizure susceptibility in mice.
Keywords: Shank3, autism spectrum disorder, patient mutations, self-grooming, anxiety-like behavior,
excitability, EEG, seizure susceptibility
INTRODUCTION
Shank proteins, a family of postsynaptic scaffolding proteins with three known members, have
been implicated in the regulation of excitatory synapse assembly and function (Sheng and Kim,
2000, 2011; Sheng and Sala, 2001; Boeckers et al., 2002; Sheng and Hoogenraad, 2007; Grabrucker
et al., 2011; Jiang and Ehlers, 2013; Sala et al., 2015; Monteiro and Feng, 2017; Mossa et al., 2017).
The third member of the family, Shank3, also known as ProSAP2, contains multiple domains
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for protein-protein interactions, including an SPN (Shank/
ProSAP N-terminal) domain, ankyrin repeats, an SH3 domain,
a PDZ domain, a proline-rich region, and a SAM (sterile alpha
motif) domain (Du et al., 1998; Boeckers et al., 1999; Lim et al.,
1999; Naisbitt et al., 1999; Sheng and Kim, 2000). These domains
mediate interactions with diverse synaptic proteins, including
GKAP (also known as SAPAP1 and DLGAP1) and Homer.
Clinically, SHANK3 has been implicated in multiple
neurodevelopmental and psychiatric disorders, including autism
spectrum disorders (ASD), Phelan-McDermid syndrome (PMS),
schizophrenia, intellectual disability, and mania (Bonaglia et al.,
2001; Wilson et al., 2003; Durand et al., 2007; Moessner et al.,
2007; Gauthier et al., 2010; Bonaglia et al., 2011; Hamdan et al.,
2011; Leblond et al., 2012; Boccuto et al., 2013; Han et al., 2013;
Guilmatre et al., 2014; Leblond et al., 2014; Cochoy et al., 2015;
Nemirovsky et al., 2015; de Sena Cortabitarte et al., 2017; De
Rubeis et al., 2018). Importantly, SHANK3 mutations have been
shown to account for∼1% of all ASD cases (Leblond et al., 2014).
Multiple lines of Shank3-mutant mice and, more recently, rats
that carry global, conditional and point mutations in Shank3,
have been generated and characterized, providing information
about normal and disease-related functions of Shank3 (Bozdagi
et al., 2010; Peca et al., 2011; Wang et al., 2011; Schmeisser et al.,
2012; Yang et al., 2012; Han et al., 2013; Kouser et al., 2013; Lee
et al., 2015; Speed et al., 2015; Jaramillo et al., 2016, 2017; Mei
et al., 2016; Wang et al., 2016; Zhou et al., 2016; Harony-Nicolas
et al., 2017; Vicidomini et al., 2017; Amal et al., 2018; Berg
et al., 2018; Bey et al., 2018; Drapeau et al., 2018; Engineer et al.,
2018; Fourie et al., 2018; Heise et al., 2018; Jin et al., 2018; Ma
et al., 2018; Qin et al., 2018; Yoo et al., 2018; Zhu et al., 2018;
Balaan et al., 2019; Rendall et al., 2019). These animals display
diverse synaptic, neuronal, circuit and behavioral abnormalities,
providing substantial insight into how Shank3 mutations lead
to various phenotypic abnormalities in mice (Jiang and Ehlers,
2013; Harony-Nicolas et al., 2015; Sala et al., 2015; Ferhat et al.,
2017; Monteiro and Feng, 2017; Mossa et al., 2017; Tan and
Zoghbi, 2018). However, with the exception of recent studies on
two mouse lines carrying an ASD-linked InsG3680 mutation and
a schizophrenia-linked R1117X mutation (Zhou et al., 2016) and
a mouse line carrying the S685I mutation (Wang et al., 2019),
mouse lines expressing point mutations of Shank3 identified
in human individuals with ASD, PMS, or other disorders have
not been reported.
The Shank3 Q321R mutation was identified as a de novo
mutation in an individual with ASD who displayed symptoms
including social and language deficits, repetitive behaviors (verbal
repetitive behaviors, hair pulling, but no motor stereotypies),
restricted interests, inattention and irritability (Moessner et al.,
2007). This mutation has been shown to decrease excitatory
synaptic targeting of Shank3 and Shank3-dependent dendritic
spine development, decrease F-actin levels in spines, and suppress
excitatory synaptic transmission in cultured hippocampal
neurons (Durand et al., 2012). In a more recent study, this
mutation was shown to enhance the interaction of Shank3 with
Sharpin, but not with α-fodrin (Mameza et al., 2013), two known
ligands of the ARR (ankyrin repeat region) domain of Shank3
(Bockers et al., 2001; Lim et al., 2001). In addition, the Q321R
mutation has stronger influences on excitatory synapses, as
compared with other Shank3 mutations such as R12C and R300C
(Durand et al., 2012). These results indicate that the Q321R
mutation exerts a significant influence on ASD-related behaviors
and excitatory synapse development and function. However,
in vivo functions of the Q321R mutation have not been explored.
In the present study, we generated and characterized a
new Shank3-mutant mouse line carrying the Q321R mutation
(Shank3Q321R mice) and studied its in vivo effects. We
found that this mutation leads to destabilization of Shank3
protein, decreased excitability in hippocampal CA1 pyramidal
neurons, enhanced self-grooming and anxiolytic-like behavior,
altered electroencephalogram (EEG) patterns, and decreased
seizure susceptibility.
MATERIALS AND METHODS
Structural Modeling of the Shank3
Protein Containing a Q321R Mutation
The structure of the SPN and ARR domains of the mouse
Shank3 protein containing the p.Q321R missense mutation was
modeled using the mutagenesis function in PyMOL software
(version 1.3) (DeLano, 2009) based on the crystal structure of
the SPN and ARR domains of the rat Shank3 protein (PDB
ID: 5G4X). Energy minimization and loop flexible modeling
were performed using Modeller software (Fiser et al., 2000).
Electrostatic charge distribution surfaces were calculated and
represented using PyMOL software (version 1.3) (DeLano, 2009).
All structural figures were prepared using PyMOL software
(version 1.3) (DeLano, 2009).
Stability Prediction of Mutant
Shank3 Proteins
The stability of the SPN and ARR domains of Shank3 containing
the ASD-risk missense mutations, p.R12C, p.L68P, p.A198G,
p.R300C, or p.Q321R, were predicted using the in silico algorithm
in I-Mutant 2.0 (version 2.0)1 under conditions of pH 7.0 and
25◦C (Capriotti et al., 2005). I-Mutant 2.0 is a support vector
machine (SVM)-based web server for automatic prediction of
stability changes upon a single point mutation. We used the
crystal structure of the SPN and ARR domains of Shank3 protein
(PDB ID: 5G4X) as a template structure to calculate changes
in the stability of the protein containing ASD-risk missense
mutations. The 11G value was calculated by subtracting the
unfolding Gibbs free energy of wild-type (WT) protein from
that of the mutated protein (kcal/mol). A negative 11G value
indicates a decrease in the stability of the mutated protein.
Animals
A mouse embryonic stem (ES) cell line harboring the Shank3
Q321R mutation was generated by Cyagen. ES cells were injected
into C57BL/6N blastocysts to produce chimeric mice, which were
crossed with WT C57BL/6J to produce heterozygous knock-in
1http://folding.biofold.org/i-mutant/i-mutant2.0.html
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(KI) F1 mice. F1 mice were then crossed with protamine-Cre
mice to remove the Neo cassette, followed by backcrossing into
a C57BL/6J background for more than five generations. All mice
used for experiments in the present study were obtained by
mating heterozygotes (HT x HT). The average WT:HT:KI ratio
was 0.94:1.94:1.12, consistent with the expected 1:2:1 Mendelian
ratio. Breeding was successful in>95% of cases, and homozygous
Shank3Q321R mice showed survival rates and body weights
comparable to those of WT mice. The mice were fed ad libitum
under 12-h light-dark cycles, and 2–6 mice were grouped in
each cage. Mice were bred and maintained according to the
Animal Research Requirements of KAIST, and all procedures
were approved by the Committee of Animal Research at KAIST
(2016-30). For PCR genotyping, the following oligonucleotide
primers were used to detect a band of 478 base pairs for WT allele
and a band of 622 base pairs for the Q321R mutant allele: forward,
5′-CAT GAG GCA CCC TTT TCT GT-3′, reverse, 5′-TGT CCC
TAA CCC CAA TGT GT-3′.
Western Blot
Brains from Shank3Q321R mice (Shank3Q321R/Q321R and
Shank3+/Q321R) and their WT littermates (3 months) were
extracted in ice-cold homogenization buffer (0.32 M sucrose,
10 mM HEPES, 2 mM EDTA, 2 mM EGTA, protease inhibitors
and phosphatase inhibitors) and homogenized by motorized
tissue grinder. Brain whole lysates were prepared by boiling with
β-mercaptoethanol. After immunoblotting with antibodies to
Shank3 (Santa Cruz SC-30193; H-160) and α-tubulin (Sigma
T5168), fluorescent secondary antibody signals were detected
using Odyssey Fc Dual Mode Imaging System.
Immunohistochemistry
Adult mice (2 months, female) were anesthetized and perfused
transcardially with 4% paraformaldehyde. Brains were removed
and post-fixed overnight at 4◦C followed by Vibratome
sectioning (50 µm; Leica VT 1200S). After washing in phosphate-
buffered saline (PBS), brain sections were blocked in 5% bovine
serum albumin (BSA) in PBS for 3–5 h. Brain sections were
incubated with primary antibodies (NeuN, 1:1000, Millipore) in
5% BSA overnight at 4◦C and washed three times for 20 min in
0.2% TritonX-100 in PBS (PBST). After incubation with Alexa
594 secondary antibody (1:500, Jackson ImmunoResearch) at
room temperature for 1 h, sections were washed three times
for 10 min in PBST. Brain sections were mounted with DAPI
mounting medium. Brain sections were imaged with a confocal
microscope (10x objective; LSM780, Carl Zeiss).
Behavioral Assays
Behavioral analyses were performed during light-off periods
on male 2–4-month-old male or female mice in their home
cages. WT and mutant littermates (partly pairs) from several
mother mice were used to form a cohort. All mice were handled
for 10 min per day for 3 days by experienced researchers
prior to behavioral experiments. Mouse behavioral assays
were performed in the following order: Laboras monitoring
of 96-h movements, open-field test, novel-object–recognition
test, repetitive behaviors, three-chamber social-interaction test,
elevated plus-maze (EPM) test, light-dark test, courtship adult
ultrasonic vocalization (USV), and contextual fear conditioning.
Laboras
Long-term locomotion and behaviors of mice were recorded
and analyzed using the Laboratory Animal Behavior Observation
Registration and Analysis System (LABORASTM) by Metris. Mice
without habitation to the behavioral booth or Laboras cages were
put into Laboras cages where recordings were conducted for 96
consecutive hours. Laboras results were not validated by manual
analyses because similar Laboras validations have been reported
(Van de Weerd et al., 2001; Quinn et al., 2003; Quinn et al., 2006;
Dere et al., 2015).
Open-Field Test
The open-field test was performed as described previously (Gould
et al., 2009). A subject mouse was gently introduced into the
center zone of the white acryl chamber (40 × 40 × 40 cm) and
recorded of movements for 1 h. Locomotor activities and time
spent in the center region (20 × 20 cm) of the open field arena
were analyzed using EthoVision XT 10 (Noldus).
Novel Object Recognition Test
Novel object recognition memory (Antunes and Biala, 2012)
was measured as follows. Briefly, after 1-h habituation in the
white acryl chamber 1 day before the experimental day, the
subject mouse was allowed to explore two objects of the same
shape and material placed symmetrically in the center of the
chamber for 10 min. Twenty-four hour later, one object was
replaced by a novel object, and the subject mouse was allowed
to explore the two objects (one novel and the other familiar)
for 10 min. Exploration was defined as events in which the
mouse sniffs the object within 1 cm distance or climbs up
the object. Time spent in sniffing each object was analyzed by
EthoVision XT 10 (Noldus) using the movies from the first
5 min to minimize saturation effects. Genotype comparisons
were made using the discrimination index [time spent exploring
novel object – time spent exploring familiar object)/(time spent
exploring novel+ familiar objects) ∗ 100], as previously described
(Stefanko et al., 2009; Vogel-Ciernia and Wood, 2014).
Repetitive Behaviors
Autism-relevant repetitive behaviors (Silverman et al., 2010)
was measured as follows. The subject mice were allowed to
freely move in a clean new home cage with bedding (∼60 lux).
Time spent in digging and self-grooming during the 10-min
session from a single recording was measured manually in a
blind manner. Digging was defined as a mouse uses its head
or forelimbs to dig out beddings. Self-grooming was defined
as a mouse stroking or scratching its face or body area, or
licking its body.
Three-Chamber Social Interaction Test
The three-chamber test, known to measure social approach and
social novelty-recognition behavior (Moy et al., 2004; Nadler
et al., 2004; Silverman et al., 2010), was performed as previously
described (Lee et al., 2015). Briefly, the subject mice were
isolated for 4 days before this assay. Three-chambered apparatus
Frontiers in Molecular Neuroscience | www.frontiersin.org 3 June 2019 | Volume 12 | Article 155
fnmol-12-00155 June 14, 2019 Time: 17:28 # 4
Yoo et al. Abnormal Phenotypes in Shank3-Q321R-Mutant Mice
(60× 40× 20 cm) consisted of the left, center, and right chamber
with two entrances to the center chamber. Two empty containers
were located in the corner of left and right chamber but not the
center chamber. This assay consisted of three sessions. First, the
subjects were allowed to freely explore all three chambers for
10 min. Second, the subject mouse was allowed to explore the
containers with a stranger 1 (S1) or a novel object (O) for 10 min.
Finally, the novel object was replaced with a stranger 2 (S2),
and the subject mouse was allowed to explore S1 and S2 for
10 min. During the interval between each session, the subject
was gently guided to the center chamber and the two entrances
were blocked. Analysis of time spent in sniffing stranger/object
was performed using EthoVision XT 10 (Noldus)
Elevated Plus-Maze Test
The EPM test (Pellow et al., 1985) was performed as follows.
Briefly, the EPM apparatus, located 75 cm above the floor,
consisted of two open arms (30 × 5 × 0.5 cm), two closed arms
(30 × 5 × 30 cm), and a center zone with access to both arms.
Light conditions were 180 lux for open arms and 20 lux for
closed arms. A subject mouse was gently introduced into the
center zone and allowed to move freely the open and closed arms
for 8 min. Time spent in open/closed arms was measured using
EthoVision XT 10 (Noldus).
Light-Dark Test
The light-dark test (Bourin and Hascoet, 2003) was performed
as previously described (Ikeda et al., 1995) with minor
modifications. Animals were placed in the light chamber with
their heads toward the opposite wall from the dark chamber, and
allowed to explore the light-dark apparatus (20 × 30 × 20 cm,
670 lux for light chamber, 20 × 13 × 20 cm, 5 lux for dark
chamber), which has a 5-cm wide entrance between the two
chambers. Time spent in the light chamber was analyzed using
EthoVision XT 10 (Noldus).
Direct Social Interaction Test
Direct social interaction test was performed as described
previously (Chung et al., 2015). Mice, which were isolated in
their home cage for 4 days, were used in this assay. On the
day of habituation, mice were individually habituated in gray
acryl box (33 × 33 × 22 cm) for 10 min. On the day for
experiments, two mice in the same genotype that never met
each other previously were put into the habituated box and
allowed to freely interact each other for 10 min while all behaviors
were recorded. Time spent in interaction such as nose-to-nose
sniffing, following, nose-to-tail sniffing, and other interactions
such as body contacts and huddling were measured manually
in a blind manner.
Courtship Adult Ultrasonic Vocalization
Courtship ultrasonic vocalizations (Portfors, 2007) was measured
as follows. Male adult subject mice were socially isolated in their
home cages for 4 days to allow them to recognize the cage as
their own territory. Female adult stranger mice were group-
caged prior to these experiments on the assumption that group
housing might synchronize female cycles. A subject male mouse
was habituated to a novel test cage for 5 min while recording
its basal vocalizations in the absence of a female stranger.
Next, a female stranger mouse was introduced into the subject’s
cage, and the two mice were allowed to interact freely with each
other while recording courtship USVs of the subject mouse for
5 min. Because courtship USVs in the context of male-female
encounters are mainly produced by males (Maggio and Whitney,
1985; Egnor and Seagraves, 2016), USVs were not categorized as
arising from male or female mice. Avisoft SASLab Pro was used
to analyze USVs.
Contextual Fear Conditioning and Extinction Test
Contextual fear conditioning and extinction (Phillips and
LeDoux, 1992; Milad and Quirk, 2002) were measured as
described previously (Lee et al., 2012). The fear conditioning
test consisted of two sessions performed on consecutive days.
On day 1, subject mice were introduced to the conditioning
box and allowed to freely explore the environment for 120 s,
and then received a series of 0.8 mA electric foot shocks (1 s;
without associated auditory cue) for five times at intervals of
120 s. After the last shock the mice were left in the box for an
additional 120 s, making the total experimental time 12 min.
On day 2, the mice were placed in the same conditioning box
and allowed to freely explore for 10 min without any stimuli,
and the freezing levels of the mice on the test day (day 2) were
quantified for the first 3 min. These mice, which were tested for
24-h fear memory, were exposed to the same context for 5 min
to measure fear extinction every day during the following 7 days
(days 3–9). All freezing behaviors were recorded and analyzed
using FreezeFrame software (Coulbourn Instruments).
Hot Plate Test
Hot plate test was performed as previously described (Ankier,
1974) with minor modifications. The subject mice were placed in
the clear acryl chamber (10× 10× 15 cm), which was located on
an aluminum heat controller (Sun Electronics Co.) maintained at
50–51◦C. Times taken for the animals to lick their fore-/hindpaws
or to jump were measured.
Von Frey Test
The von Frey test was performed according to the standard
operating procedures of the Jackson Laboratory Mouse
Neurobehavioral Phenotyping Facility (JAX-MNBF). The von
Frey test apparatus consisted of a wire floor grid and a clear
observation arena with aerated lids (Stoelting Co.). A subject
mouse was gently introduced in the observation arena and
habituated for 1 h until the activity levels become low. Beginning
with the left hind paw, stimuli of von Frey filaments (Stoelting
Co.) were presented perpendicularly to the plantar surface of the
hind paws of the subject mice for two trials. The initial stimulus
started with a von Frey filament with 0.4 g bending force. When
there is a withdrawal response, the strength of the stimulus was
gradually decreased to lower bending forces (0.16 to 0.02 g),
while the stimulus was increased to a higher bending force (0.6 g)
when there was no response. The minimum threshold required
to induce a withdrawal response for left and right paws was
recorded. A withdrawal response is defined as the mouse lifting
up their hind paws when a filament is pushed with increasing
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pressure until it bends. All experimental procedures and analysis
were performed in a double-blinded manner.
Electrophysiology
Male or female mice were used for electrophysiological
measurements (details are described in figure legends). After
anesthetization with isoflurane, mouse brains were removed,
and sagittal sections (300 µm) including hippocampus or
striatum were prepared using a Vibratome (Leica VT 1200S)
in ice-cold section buffer (in mM: 212 sucrose, 25 NaHCO3,
5 KCl, 1.25 NaH2PO4, 10 D-glucose, 1.2 L-ascorbic acid, 2 Na-
pyruvate, 3.5 MgSO4, 0.5 CaCl2). Slices were maintained in
artificial cerebrospinal fluid (ACSF) (in mM: 124 NaCl, 25
NaHCO3, 10 glucose, 2.5 KCl, 1 NaH2PO4, 2.5 CaCl2, 1.25
MgCl2) bubbled with 95% O2 and 5% CO2 for 30 min at 32◦C
followed by incubation for 30 min at room temperature. For
mEPSC measurements, ACSF contained tetrodotoxin (0.5 µM)
and picrotoxin (60 µM). Whole-cell recordings of pyramidal
neurons in the hippocampal CA1 region were performed using
a recording pipette filled with internal solution (in mM: 100
CsMeSO4, 10 TEA-Cl, 8 NaCl, 10 HEPES, 5 QX-314-Cl, 2 Mg-
ATP, 0.3 Na-GTP and 10 EGTA with pH 7.25, 295 mOsm). For
mIPSC measurement, ACSF contained tetrodotoxin (0.5 µM),
NBQX (10 µM), and AP5 (50 µM). Whole-cell recordings
of pyramidal neurons in the hippocampal CA1 region were
performed with a recording pipette filled with internal solution
(in mM: 115 CsCl, 10 TEA-Cl, 8 NaCl, 10 HEPES, 5 Qx-
314-Cl, 4 Mg-ATP, 0.3 Na-GTP, 10 EGTA with pH 7.35, 295
mOsm). For neuronal excitability measurement, ACSF contained
picrotoxin (60 µM), NBQX (10 µM), and AP5 (50 µM). Whole-
cell recordings in pyramidal neurons in the hippocampus CA1
region were performed with a recording pipette filled with
internal solution (in mM: 137 K-gluconate, 5 KCl, 10 HEPES,
0.2 EGTA, 10 Na2-phosphocreatine, 4 Mg-ATP, 0.5 Na-GTP with
pH 7.2, 280 mOsm). First minimal currents were introduced
to hold the membrane potential around −70 to −75 mV
in a current clamp mode. To evoke depolarizing voltage sag
responses, increasing amounts of depolarizing step currents (by
10 pA, −150 to 20 pA) were injected. Then, to elicit action
potentials, increasing amounts of depolarizing currents (0 to
330 pA) were injected in a stepwise manner. Input resistance was
calculated as the linear slope of current-voltage plots generated
from a series of increasing current injection steps. The sag ratio
was determined as the ratio of a steady state value to repolarized
peak at the entire length of injected current at each step. The
synaptic responses were amplified (Multiclamp 700B, Molecular
Devices) and digitized (Digidata 1550, Molecular Devices) for
analyses. mE/IPSCs were analyzed using Clamfit 10.4 software
and horizontally spread-out currents where the high noise levels
that are visible in horizontally compressed currents do not inhibit
accurate analyses of the currents.
Electroencephalography
Electroencephalography (EEG) recording was performed as pre-
viously described with minor modifications (Lee et al., 2018).
An EEG driver was composed of a small header pin connector
socket (Hirose Electric, H2021-ND) connected with six stainless
steel screws (1 mm × 3 mm) through soldered coated stainless
steel wire. All screws were implanted on the skull (two for
bilateral frontal, +1.8 mm AP, ±1.0 mm ML; two for bilateral
parietal, −2.0 mm AP and ±1.8 mm ML; two for animal
ground and reference, −1.0 mm AP and ±1.0 mm ML from
lambda). After recovery 1 week after the surgery, EEG recordings
were performed using a Cheetah Data Acquisition System
(Neuralynx). The subject mice were allowed to freely move
around in a white acryl box (25× 25× 35 cm) with synchronized
video recording. After 20-min habituation in the box, EEGs were
recorded for 40 min. EEG data were analyzed using a customized
MATLAB code. Baseline EEGs were analyzed using 5-min serial
samplings, and the total power spectral density (PSD) was
averaged per mouse by applying Fast Fourier Transform (FFT).
EEG frequency ranges were defined as follows; Delta, 0–4 Hz;
theta, 4–12 Hz; alpha, 12–30 Hz; low gamma, 30–80 Hz; high
gamma, 80–130 Hz.
PTZ-Induced Seizure Susceptibility
To determine the susceptibility of mice to PTZ-induced seizures,
we performed the experiments using mice that did not receive
EEG driver surgery for cleaner results. After intraperitoneal
injection of PTZ (Sigma; 50 mg/kg), subject mice were placed
in a clean new home cage. Video recordings for 20 min were
used to analyze seizure stages defined as follows; stage 1,
behavioral arrest; stage 2, myoclonic (jerk) seizures; stage 3:
general tonic-clonic seizures, as previously described (Naydenov
et al., 2014). The seizure susceptibility score was defined as
follows; 0.2 × (latency to stage 1) + 0.3 × (latency to stage
2)+ 0.5× (latency to stage 3).
Statistical Analysis
All behavioral, biochemical, and electrophysiological experi-
ments were performed by researchers blinded to the experimental
conditions. Statistical analyses were performed using GraphPad
Prism 7 and MATLAB. Data sets, after removal of outliers, were
analyzed for significance using unpaired two-tailed Student’s
t-test, Mann–Whitney U-test, one-sample t-test, log-rank test,
and two-way analysis of variance (ANOVA) with post hoc
multiple comparisons test when appropriate. The n values and
statistical significance values are indicated in figure legends.
Statistical significance values are indicated as follows in the
figures: ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ns, not significant.
Additional statistical details and results, as well as information
on sex, age and numbers of mice used, are presented in
Supplementary Table S1.
RESULTS
Molecular Modeling of the
Shank3 Q321R Mutation
The Q321R mutation in the SHANK3 gene (Moessner et al.,
2007), which strongly influences the synaptic targeting of Shank3
and the development and function of dendritic spines and
excitatory synapses (Durand et al., 2012), is located in the
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FIGURE 1 | Molecular modeling-based predictions of protein stability and surface charge distribution in SPN-ARR domains of the Shank3 protein harboring Q321R
and other ASD-risk mutations. (A) Structure of the SPN and ARR domains of the Shank3 protein (PDB ID: 5G4X), with the locations of amino acid residues mutated
in autistic individuals (R12C, L68P, A198G, R300C, and Q321R) indicated. The SPN domain, the linker connecting the SPN and ARR domains, and the ARR domain
of Shank3 are indicated in gray, green, and orange colors, respectively, as a ribbon diagram. The ASD-risk residues are indicated by ball-and-stick models.
(B) Stability predictions of SPN and ARR domains of the Shank3 protein containing the indicated ASD-risk mutations, obtained using I-Mutant 2.0 software.
A negative predicted free energy change (11G, in kcal/mol) indicates a decrease in the stability of the mutant protein. (C) Electrostatic surface charge distribution
patterns in WT and mutant (Q321R) SPN and ARR domains of the Shank3 protein. Negative and positive surface charges are indicated in red and blue, respectively.
Hydrophobic surfaces are indicated in white. Surface areas with the Shank3 Q321R mutation are indicated by dotted orange circles.
ARR domain of the protein. The ARR domain of Shank3 has
been shown to interact with the N-terminal SPN domain of
Shank3 in an intramolecular manner, leading to suppression
of the binding of the ARR domain to Sharpin and α-fodrin
(Mameza et al., 2013). These results suggest the possibility
that these intra- and intermolecular interactions of the SPN
and ARR domains of Shank3 might underlie the effects of
the Q321R mutation.
Using the recently reported X-ray crystal structure of the
N-terminal SPN and ARR domains of Shank3 (Lilja et al., 2017),
we attempted molecular modeling of the SPN and ARR domains
harboring the Q321R mutation to determine whether the
mutation could interfere with the interaction between these two
domains (Figure 1A). We also included the following additional
ASD-risk Shank3 mutations in SPN and ARR domains in our
modeling (Durand et al., 2007; Moessner et al., 2007; Gauthier
et al., 2010): L68P, which disrupts the interaction between the
SPN and ARR domains and enhances the interactions of the
ARR with Sharpin (Mameza et al., 2013); R12C, which affects
excitatory synapse structure and function (Durand et al., 2012)
and disrupts SPN binding to GTP-bound Ras and Rap small
GTPases to suppress integrin signaling (Lilja et al., 2017); and
R300C, which affects excitatory synapse structure and function
(Durand et al., 2012).
We found that the Q321R mutation, unlike the L68P
mutation, is located in the C-terminal region of the ARR domain,
away from the interface of the SPN and ARR domains, and
thus is unlikely to affect the SPN-ARR interaction (Figure 1A).
We next tested whether these mutations affect the stability of
SPN and ARR domains by calculating changes in free energy.
All five mutations, including the Shank3 Q321R mutation,
induced significant decreases in the stability of the protein, with
the A198G mutation exerting the strongest effect (Figure 1B),
although the impact of the A198G mutation has not been
explored in previous in vitro studies (Durand et al., 2012;
Mameza et al., 2013). In addition, an analysis of surface
charge distribution indicated that the Q321R mutation induces
a substantial increase in the local positive charge density
(Figure 1C). These results suggest that the Q321R mutation
is less likely to affect the intramolecular SPN-ARR interaction,
but more likely to affect the protein stability or intermolecular
interactions of Shank3.
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FIGURE 2 | Generation and characterization of Shank3Q321R mice. (A) A schematic diagram showing the location of the Shank3 Q321R mutation in the Shank3
protein. Ank, ankyrin repeat region; SH3, Src homology 3 domain; PDZ, PSD-95/Dlg/ZO-1 domain; Proline-rich, proline-rich region; SAM, sterile alpha motif domain.
(B) A schematic diagram showing the gene-targeting strategy used to generate Shank3Q321R mice. Note that the mutated codon corresponding to the Q321R
mutation is located in exon 8 of the Shank3 gene. Primers (forward and reverse) for PCR genotyping are indicated. Neo, neomycin resistance; DTA, diphtheria toxin.
(C) Confirmation of the Shank3Q321R mutation by genomic DNA sequencing of Shank3Q321R/Q321R mice. Results from a wild-type (WT) mouse are shown for
comparison. (D) PCR genotyping of Shank3Q321R/Q321R (HM/homozygous) and Shank3+/Q321R (HT/heterozygous) mice. (E) Known Shank3 protein variants. The
target region (aa 1431–1590) of the Shank3 antibody used in the immunoblot analysis (F) is indicated. (F) The levels of Shank3a, but not Shank3c/d or Shank3e,
protein variants, are substantially decreased in whole-brain lysates from WT and Shank3Q321R/Q321R and Shank3+/Q321R mice (2 months; female), as determined by
immunoblot analysis using Shank3-specific antibodies targeting amino acids 1431–1590 in the proline-rich region of the protein that can detect all three protein
splice variants. n = 3 mice (WT, HT, and HM), ∗P < 0.05, ∗∗P < 0.01, ns, not significant, One sample t-test. (G) Normal gross morphology of the brains of WT and
homozygous Shank3Q321R/Q321R mice (2 months; female), as shown by immunostaining of coronal sections for the neuronal marker, NeuN. Scale bar, 1 mm.
Generation and Characterization of
Shank3Q321R Mice
To determine in vivo impacts of the Shank3 Q321R mutation,
we generated a new knock-in (KI) mouse line carrying this
mutation (Shank3Q321R mice) (Figures 2A,B). DNA sequencing
confirmed the Shank3Q321R mutation (Figure 2C), and wild-type
(WT) and Shank3Q321R mice (heterozygous Shank3+/Q321R and
homozygous Shank3Q321R/Q321R) were detected by polymerase
chain reaction (PCR) genotyping (Figure 2D).
The mutated codon corresponding to the Shank3 Q321R
mutation is located in exon 8 of the Shank3 gene, which encodes
the C-terminal region of the ARR domain of the Shank3 protein.
Therefore, among the multiple variants of the Shank3 protein,
Shank3a and Shank3b, containing the ARR domain (Figure 2E),
would be most strongly affected compared with ARR-lacking
Shank3c/d/e variants (Lim et al., 1999; Maunakea et al., 2010;
Wang et al., 2011, 2014; Waga et al., 2014; Zhu et al., 2014).
Indeed, the levels of Shank3a, the longest (∼240 kDa) variant,
which is readily detected by an antibody targeting the proline-rich
region (aa 1431–1590), were significantly decreased (by∼18%) in
homozygous Shank3Q321R/Q321R brains (Figure 2F), in line with
the predicted destabilization of the Shank3 protein noted above.
Detection of Shank3b protein, which lacks a large portion of the
proline-rich region, was not possible because the antibody used
targets the proline-rich region. In heterozygous Shank3+/Q321R
brains, Shank3a levels were comparable to those in WT mice,
indicative of less severe protein degradation of the mutant Shank3
protein in the heterozygous Shank3-mutant brain.
Shank3Q321R/Q321R and Shank3+/Q321R mice were born in
the expected Mendelian ratios. In addition, Shank3Q321R/Q321R
mice displayed no detectable abnormalities in the size or gross
morphology of the brain, as shown by staining for the neuronal
marker, NeuN (Figure 2G).
Suppressed Neuronal Excitability in
Homozygous Shank3Q321R/Q321R
Hippocampal CA1 Pyramidal Neurons
To determine the effect of the Shank3 Q321R mutation
on synaptic transmission and neuronal excitability, we
first measured spontaneous synaptic transmission in the
hippocampus, a brain region implicated in ASD (Amaral et al.,
2008). The frequency and amplitude of miniature excitatory
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FIGURE 3 | Suppressed neuronal excitability but normal mEPSCs and mIPSCs in hippocampal CA1 pyramidal neurons from male Shank3Q321R/Q321R mice.
(A) Normal mEPSC frequency and amplitude in CA1 pyramidal neurons in the hippocampus of male Shank3Q321R/Q321R mice (P21–25). The indicated values
represent means ± SEM. n = 14 neurons from 3 mice (WT) and 15 neurons from 3 mice (Q321R), ns, not significant, Mann–Whitney U-test (for frequency) and
Student’s t-test (for amplitude). (B) Normal mIPSC frequency and amplitude in CA1 pyramidal neurons in the hippocampus of male Shank3Q321R/Q321R mice
(P21–25). n = 12 neurons from 5 mice (WT) and 13 neurons from 3 mice (Q321R), ns, not significant, Student’s t-test (for frequency) and Student’s t-test (for
amplitude). (C–F) Suppressed neuronal excitability in hippocampal CA1 pyramidal neurons from male Shank3Q321R/Q321R mice (P22–26), as shown by the number
of action potential fired plotted against injected currents (F). Note that the current-voltage relationship (C), input resistance (D), and Sag ratio (E) were not changed.
n = 14 neurons from 5 mice (WT) and 16 neurons from 4 mice (Q321R), ∗P < 0.05, ∗∗∗P < 0.001, ns, not significant, repeated measures two-way ANOVA (for
current-membrane potential and current-firing curves) and Mann–Whitney U-test (for input resistance and sag ratio). (G) Normal mEPSC frequency and amplitude in
dorsolateral striatal neurons from male Shank3Q321R/Q321R mice (P28–43). n = 16 neurons from 4 mice (WT) and 16 neurons from 5 mice (Q321R), ns, not
significant, Mann–Whitney U-test (for frequency) and Student’s t-test (for amplitude). (H) Normal mIPSC frequency and amplitude in dorsolateral striatal neurons from
male Shank3Q321R/Q321R mice (P28–43). n = 16 neurons from 6 mice (WT) and 17 neurons from 7 mice (Q321R), ns, not significant, Student’s t-test (for frequency)
and Mann–Whitney U-test (for amplitude).
postsynaptic currents (mEPSCs) in CA1 pyramidal neurons
from the hippocampus of homozygous Shank3Q321R/Q321R
mice (P21–25; male) were comparable to those from WT
neurons (Figure 3A). Similarly, the frequency and amplitude
of miniature inhibitory postsynaptic currents (mIPSCs) were
normal in hippocampal CA1 pyramidal neurons from male
Shank3Q321R/Q321R mice (P21–25; male) (Figure 3B).
When female mice were tested for mEPSCs and mIPSCs,
the frequency, but not amplitude, of mIPSCs was increased in
CA1 pyramidal neurons (P22–26), whereas mEPSC frequency
and amplitude in these neurons (P21–27) were normal
(Supplementary Figures S1A,B). Given that Shank proteins
are mainly present at excitatory, but not inhibitory, synapses
(Boeckers et al., 1999; Naisbitt et al., 1999; Tu et al., 1999; Yao
et al., 1999; Bockmann et al., 2002; Heise et al., 2016), these
results likely represent a secondary change rather than the direct
consequence of Shank3 deletion in pyramidal neurons.
We next measured the neuronal excitability of CA1 pyramidal
neurons from Shank3Q321R/Q321R mice (P22–26; male). Neuronal
excitability was decreased, as evidenced by the relationship
between the amount of injected current and the number of
action potentials fired, but the current-voltage relationship, input
resistance, and Sag ratio were normal (Figures 3C–F). These
results collectively suggest that the Shank3 Q321R mutation
suppresses neuronal excitability in male CA1 pyramidal neurons,
which would suppress the output function of these neurons.
In addition to the hippocampus, we measured mEPSCs and
mIPSCs in the striatum, a brain region strongly implicated in
the pathophysiology of Shank3-related autistic-like phenotypes
in mice (Peca et al., 2011; Peixoto et al., 2016; Lee et al., 2017).
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FIGURE 4 | Normal locomotor activity and moderate anxiolytic-like behavior in heterozygous Shank3+/Q321R mice. (A,B) Normal locomotor activity in
Shank3+/Q321R mice (2–3 months; male) in Laboras cages, where locomotor activity was measured together with other movements for four consecutive days in the
absence of habituation. OFF/ON, light-off/on. n = 13 mice (WT) and 13 mice (HT), ns, not significant, two-way ANOVA (genotype main effect p-value = 0.1813 in A),
and Student’s t-test (B). (C,D) Normal locomotor activity in Shank3+/Q321R mice (2–3 months; male) in the open-field test, as shown by the distance moved. n = 13
mice (WT) and 13 mice (HT), ns, not significant, repeated measures two-way ANOVA (C) and Student’s t-test (D). (E) Normal anxiety-like behavior in Shank3+/Q321R
mice (2–3 months; male) in the open-field test, as shown by the time spent in the center region of the open-field arena. n = 13 mice (WT) and 13 mice (HT), ns, not
significant, Mann–Whitney U-test. (F) Normal anxiety-like behavior in Shank3+/Q321R mice (2–3 months; male) in the elevated plus-maze test, as shown by the time
spent in the open arms of the maze. n = 13 mice (WT) and 13 mice (HT), ns, not significant, Welch’s t-test. (G) Anxiolytic-like behavior in Shank3+/Q321R mice
(2–3 months; male) in the light-dark test, as shown by the time spent in the light chamber of the light-dark apparatus. n = 13 mice (WT) and 12 mice (HT),
∗∗P < 0.01, Student’s t-test.
We found that the frequency and amplitude of mEPSCs
in dorsolateral striatal neurons in Shank3Q321R/Q321R mice
(P28–43; male) were normal (Figure 3G). In addition, mIPSC
frequency and amplitude were normal in these neurons (P28–43;
male) (Figure 3H). These results suggest that the Shank3
Q321R homozygous mutation does not affect spontaneous
excitatory or inhibitory synaptic transmission in the dorsolateral
striatum in male mice.
Normal Locomotion and Moderate
Anxiolytic-Like Behavior in Heterozygous
Shank3+/Q321R Mice
To determine the behavioral impacts of the Shank3
Q321R mutation, we next subjected Shank3+/Q321R and
Shank3Q321R/Q321R mice to a battery of behavioral tests. Previous
studies on Shank3-mutant mice have shown that Shank3
heterozygosity can lead to ASD-related behavioral abnormalities
(Bozdagi et al., 2010; Yang et al., 2012; Duffney et al., 2015;
Jaramillo et al., 2016, 2017). We thus first analyzed behavioral
abnormalities in heterozygous Shank3+/Q321R mice.
Continuous monitoring of mouse movements for
four consecutive days in Laboras cages, representing a
familiar environment, revealed that Shank3+/Q321R mice
have normal locomotor activity compared with WT mice
(Figures 4A,B). Similarly, Shank3+/Q321R mice displayed normal
locomotor activity in the open-field test, a novel environment
(Figures 4C,D). These results suggest that locomotor activities
in both familiar and novel environments are not affected by the
heterozygous Shank3 Q321R mutation.
Shank3+/Q321R and WT mice spent comparable amounts of
time in the center region of the open-field arena (Figure 4E).
In addition, Shank3+/Q321R mice spent normal amounts of
time in the open arms of the EPM (Figure 4F). In contrast,
these mice spent more time in the light chamber of the light-
dark apparatus (Figure 4G). Together, these results suggest that
the heterozygous Shank3 Q321R mutation leads to moderate
anxiolytic-like behavior but does not affect locomotor activity.
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Normal Social Interaction, Moderately
Enhanced Social Communication and
Self-Grooming, and Suppressed Digging
in Heterozygous Shank3+/Q321R Mice
Shank3+/Q321R and WT mice showed comparable levels of social
approach in the three-chamber test, as shown by time spent
sniffing social and object targets (Figure 5A). Social novelty
recognition could not be assessed because WT mice failed to
recognize a novel stranger mouse. In tests for USVs in adult
male mice encountering a novel female mouse (courtship USVs),
Shank3+/Q321R mice emitted normal numbers of USVs, but the
mean duration of each call was increased (Figure 5B), indicative
of a moderate and abnormal increase in social communication.
In tests for repetitive behaviors, Shank3+/Q321R mice displayed
enhanced self-grooming and suppressed digging in novel home
cages with bedding (10 min;∼60 lux) (Figures 5C,D), suggesting
that the suppressed digging might result from the enhanced self-
grooming. However, long-term (96-h) monitoring of behavior in
Laboras cages showed that Shank3+/Q321R mice exhibit normal
self-grooming during the first 10 min, the first 1 or 12 h, the
entire session (96 h), and during light-off and light-on periods
(48 h each) (Figures 5E–I). These results collectively suggest
that the heterozygous Shank3 Q321R mutation does not affect
social approach, moderately enhances social communication and
self-grooming, and suppresses digging in mice.
Homozygous Shank3Q321R/Q321R Mice
Show Behaviors That Are Largely Similar
to Those Observed in Heterozygous
Shank3+/Q321R Mice
To test whether there are any dose-dependent effects of
the Shank3 Q321R mutation on mouse behaviors, we
subjected homozygous Shank3Q321R/Q321R mice to a battery of
behavioral tests that were used for heterozygous Shank3+/Q321R
mice. Shank3Q321R/Q321R mice showed normal levels of
locomotor activity in Laboras cages and in the open-field test
(Figures 6A–D). In addition, these mice showed moderately
increased anxiolytic-like behaviors, as shown by normal levels of
center time in the open-field test but increased open-arm time
in the EPM and increased light-box time in the light-dark test
(Figures 6E–G), similar to heterozygous Shank3+/Q321R mice.
Social behavior was normal in homozygous
Shank3Q321R/Q321R mice, as shown by the three-chamber
test (Figure 7A), similar to heterozygous Shank3+/Q321R
mice. Again, social novelty recognition could not be assessed
because WT mice failed to recognize a novel stranger mouse.
Shank3Q321R/Q321R and WT mice showed comparable levels of
social interaction in the direct social interaction test, as shown
by the total time spent interacting with an age- and sex-matched
male stranger mouse (Figure 7B).
Homozygous Shank3Q321R/Q321R mice displayed normal
courtship USVs, as shown by the number of USV calls as
well as the duration of each USV calls (Figure 7C), partly
similar to heterozygous Shank3+/Q321R mice that displayed a
normal number of courtship USV calls but increased duration
of each USV calls. Lastly, homozygous Shank3Q321R/Q321R mice
displayed increased self-grooming and decreased digging in novel
home cages with bedding (10 min) (Figures 7D,E), but normal
Laboras-cage self-grooming (Figures 7F–J), largely similar to
heterozygous Shank3+/Q321R mice.
Because the differences between novel home-cage and
Laboras-cage environments, where both Shank3+/Q321R and
Shank3Q321R/Q321R mice showed positive and negative repetitive
self-grooming, respectively, include the novelty of the space
(less novel in new home cages and more novel in Laboras
cages) and the light intensity (bright light in home cages
and complete darkness in Laboras cages). To differentiate
these factors, we first tested a new condition, novel home-
cage environment without light, and, intriguingly, could not
observe enhanced self-grooming in Shank3Q321R/Q321R mice
(Supplementary Figure 2A), suggesting that the presence of light
is important. However, the presence of light in Laboras cages did
not enhance self-grooming in Shank3Q321R/Q321R mice during the
first 10 min (Supplementary Figure 2B), similar to the results
from Laboras cages without light. Furthermore, the presence of
light in a novel open-field arena did not enhance self-grooming
in Shank3Q321R/Q321R mice (Supplementary Figure 2C). These
results indicate that self-grooming in Shank3Q321R/Q321R mice
is enhanced selectively in novel home cages in the presence
of light. In addition, these results suggest that novelty of
space/environment per se is not important, but, rather, an
increase in stress associated with the light in novel home cages
(but not in other environments) strongly enhances self-grooming
in Shank3Q321R/Q321R mice.
Together, these results suggest that homozygous
Shank3Q321R/Q321R mice show behavioral abnormalities that are
largely similar to those observed in heterozygous Shank3+/Q321R
mice such as moderately enhanced anxiolytic-like behavior
and self-grooming, although there were minor differences
in a sub-parameter of USVs (duration of each USV calls).
In addition, the largely similar behaviors of Shank3+/Q321R
and Shank3Q321R/Q321R mice suggest that there is no strong
dose-dependent effect of the Shank3 Q321R mutation on
mouse behaviors.
Normal Novel Object-Recognition and
Contextual Fear Memory in Homozygous
Shank3Q321R/Q321R Mice
In the novel object–recognition test, in which a mouse is exposed
to two identical objects on day 1 and then to one original object
and a new object on day 2, Shank3Q321R/Q321R and WT mice
showed similar discrimination index scores for the novel object
(Figure 8A), indicative of normal object-recognition memory in
the mutant mice.
In the contextual fear-conditioning test, Shank3Q321R/Q321R
mice showed normal acquisition of fear memory on the training
day (day 1) (Figure 8B). Twenty-four hours later (day 2),
Shank3Q321R/Q321R and WT mice showed comparable levels of
freezing in the same context, suggestive of normal retrieval of
contextual fear memory. When these mice were subsequently
exposed to the same context every day for seven consecutive
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FIGURE 5 | Normal social interaction, moderately enhanced social communication and self-grooming, and suppressed digging in heterozygous Shank3+/Q321R
mice. (A) Normal social approach in Shank3+/Q321R mice (2–3 months; male) in the three-chamber test, as shown by time spent sniffing. S1, a stranger; O, object;
S2, new stranger. Social novelty recognition, measured by the preference for new stranger (S2) over old stranger (S1), could not be determined due the lack of
normal social novelty recognition in WT mice. n = 10 mice (WT), 13 mice (HT), ∗∗∗P < 0.001, ns, not significant, Welch’s t-test, Mann–Whitney U-test, and Student’s
t-test. (B) Moderately increased courtship USVs emitted by Shank3+/Q321R mice (2–3 months; male) upon encounter with a novel female stranger, as shown by the
normal number of USVs but increased mean duration of each USV calls. n = 12 mice (WT), 12 mice (HT), ∗P < 0.05, ns, not significant, Student’s t-test.
(C) Enhanced self-grooming in Shank3+/Q321R mice (2–3 months; male) in home cages with bedding (10 min), as shown by total self-grooming time. n = 12 mice
(WT), 13 mice (HT), ∗P < 0.05, Student’s t-test. (D) Suppressed digging in Shank3+/Q321R mice (2–3 months; male) in home cages with bedding (10 min), as shown
by total digging time. n = 12 mice (WT), 13 mice (HT), ∗P < 0.05, Welch’s t-test. (E–I) Normal self-grooming in Shank3+/Q321R mice (2–3 months; male) in Laboras
cages, as shown by total self-grooming duration. n = 13 mice (WT), 13 mice (HT), ns, not significant, two-way ANOVA (genotype main effect p-value = 0.4087 in E),
Mann-Whitney test (F,H,I), Student’s t-test (G).
FIGURE 6 | Normal locomotor activity and moderate anxiolytic-like behavior in homozygous Shank3Q321R/Q321R mice. (A,B) Normal locomotor activity in
Shank3Q321R/Q321R mice (2–4 months; male), in Laboras cages, where locomotor activity was measured together with other movements for four consecutive days in
the absence of habituation. Note that the WT data in this panel and other panels in this figure are identical to those shown in Figure 4 because WT, heterozygous,
and homozygous mice were tested together in the same behavioral tests. OFF/ON, light-off/on. n = 13 mice (WT) and 14 mice (Q321R), ns, not significant, two-way
ANOVA (A, genotype main effect p-value = 0.9356) and Student’s t-test (B). (C,D) Normal locomotor activity in Shank3Q321R/Q321R mice (2 months; male) in the
open-field test, as shown by the distance moved. Note that Shank3Q321R mice spent a normal amount of time in the center region of the open-field arena,
suggestive of normal anxiety-like behavior. n = 13 mice (WT) and 14 mice (Q321R), ∗∗∗P < 0.001, ns, not significant, repeated measures two-way ANOVA (C) and
Student’s t-test (D). (E) Normal anxiety-like behavior in Shank3Q321R/Q321R mice (2 months; male) in the open-field test, as shown by the time spent in the center
region of the open-field arena. n = 13 mice (WT) and 14 mice (Q321R), ns, not significant, Student’s t-test. (F) Anxiolytic-like behavior in Shank3Q321R/Q321R mice
(2 months; male) in the elevated plus-maze test, as shown by the increased time spent in the open arms of the maze. n = 13 mice (WT) and 14 mice (Q321R),
∗P < 0.05, Mann–Whitney U-test. (G) Anxiolytic-like behavior in Shank3Q321R/Q321R mice (2 months; male) in the light-dark test, as shown by the increased time
spent in the light chamber of the light-dark apparatus. n = 13 mice (WT) and 14 mice (Q321R), ∗P < 0.05, Welch’s t-test.
days (day 3–9) for fear extinction, they displayed comparable
decreases in freezing levels, suggestive of normal fear extinction
in Shank3Q321R/Q321R mice.
In addition, Shank3Q321R/Q321R mice showed normal levels of
somatosensory functions, as determined by the hot plate and von
Frey tests (Figures 8C,D). These results collectively suggest that
the homozygous Shank3 Q321R mutation does not affect object-
recognition memory, acquisition, or extinction of contextual fear
memory, or somatosensory functions.
Female Homozygous Shank3Q321R/Q321R
Mice Show Normal Anxiety-Like
Behavior and Reduced Self-Grooming
To test whether there is a male-female difference in the
impacts of the Shank3 Q321R mutation on behaviors, we
subjected female Shank3Q321R/Q321R mice to the behavioral
tests in which male Shank3Q321R/Q321R mice showed abnormal
behaviors. To our surprise, female Shank3Q321R/Q321R mice
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FIGURE 7 | Normal social interaction and communication, moderately enhanced stress-induced self-grooming, and suppressed digging in homozygous
Shank3Q321R/Q321R mice. (A) Normal social approach in Shank3Q321R/Q321R mice (3 months; male) in the three-chamber test, as shown by time spent sniffing social
(S1) or object (O) target. Social novelty recognition, measured by the preference for new stranger (S2) over old stranger (S1), could not be determined due the lack of
normal social novelty recognition in WT mice. Note that the WT data in this panel and other panels in this figure are identical to those shown in Figure 5 because
WT, heterozygous, and homozygous mice were tested together in the same behavioral tests. n = 10 mice (WT), 14 mice (Q321R), ∗∗∗P < 0.001, ns, not significant,
Welch’s t-test (for S1 vs. O) and Student’s t-test (for S1 vs. S2). (B) Normal social interaction in Shank3Q321R/Q321R mice (3 months; male) in bidirectional direct
social-interaction tests, as shown by total time spent in social interaction. n = 10 pairs (WT), 13 pairs (Q321R), ns, not significant, Student’s t-test. (C) Normal USVs
emitted by Shank3Q321R/Q321R mice (4 months; male) upon encounter with a novel female stranger (courtship USVs), as shown by the total number of USVs and the
mean duration of each USV calls. n = 12 mice (WT), 14 mice (Q321R), ns, not significant, Student’s t-test. (D) Enhanced self-grooming in Shank3Q321R/Q321R mice
(2 months; male) in home cages with bedding (10 min), as shown by total self-grooming time. n = 12 mice (WT), 13 mice (Q321R), ∗∗∗P < 0.001, Student’s t-test.
(E) Suppressed digging in Shank3Q321R/Q321R mice (2 months; male) in home cages with bedding (10 min), as shown by total digging time. n = 12 mice (WT), 13
mice (Q321R), ∗P < 0.05, Welch’s t-test. (F–J) Normal self-grooming in Shank3Q321R/Q321R mice (2 months; male) in Laboras cages, where self-grooming was
measured together with other movements for four consecutive days in the absence of habituation. OFF/ON, light-off/on. Note that there are no genotype differences
during the first 10 min, 1 or 12 h, the entire session (96 h), or during light-off and light-on periods (48 h each). n = 13 mice (WT) and 14 mice (Q321R), ns, not
significant, two-way ANOVA (genotype main effect p-value = 0.9754 in F), Student’s t-test (H) and Mann–Whitney U-test (G,I,J).
showed normal levels of anxiety-like behaviors in both EPM
and light-dark tests (Supplementary Figures 1C,D), dissimilar
to male Shank3Q321R/Q321R mice that showed anxiolytic-like
behavior in both tests (Figures 6F,G).
Furthermore, female Shank3Q321R/Q321R mice showed
normal levels of self-grooming and digging in novel home
cages with bedding (10 min) (Supplementary Figures 1E,F),
again dissimilar to male Shank3Q321R/Q321R mice that showed
enhanced self-grooming and reduced digging in novel home
cages (Figures 7D,E). These results collectively suggest that
female Shank3Q321R/Q321R mice do not show anxiolytic-like
behavior or enhanced self-grooming, dissimilar to male
Shank3Q321R/Q321R mice.
Abnormal EEG Patterns and Decreased
Susceptibility to Induced Seizures in
Homozygous Male Shank3Q321R/Q321R
Mice
Abnormal electroencephalogram (EEG) patterns have been
observed in ASD (Wang et al., 2013), ASD and PMS associated
with SHANK3 mutations (Moessner et al., 2007; Soorya et al.,
2013; Figura et al., 2014; Holder and Quach, 2016), as well as
in Shank3-mutant mouse models (Han et al., 2013; Dhamne
et al., 2017). In particular, the individual with ASD carrying
the Q321R mutation was reported to display abnormal EEG,
bilateral epileptiform discharges without seizures, and severe
sleep disorders (Moessner et al., 2007). We thus attempted
bilateral EEG recordings in the frontal and parietal lobes of the
male Shank3Q321R/Q321R brain using EEG drivers implanted on
the skull. The power of EEG in the delta range, but not other
frequency ranges (0–4 Hz), was decreased in the frontal lobes,
whereas EEG power in the alpha frequency range (12–30 Hz) was
increased in the parietal lobes (Figures 9A,B).
Abnormalities in the left-right hemispheric asymmetry of
EEGs have also been observed in ASD (Wang et al., 2013).
We thus analyzed the changes in EEGs in left and right
hemispheres of the Shank3Q321R/Q321R brain separately. In the
frontal lobe, left and right hemispheres showed similar decreases
in normalized EEG power in the delta range, but not other ranges
(Supplementary Figure 3A). Intriguingly, in the parietal lobe,
the right but not left hemisphere showed decreased EEG power
in the delta range and increased EEG power in theta and alpha
ranges (Supplementary Figure 3B). These results suggest that
the decreased delta-band EEG power in the frontal lobe likely
involves both hemispheres, whereas the increase alpha-band EEG
power in the parietal lobe likely involves the right parietal lobe.
These abnormal EEG patterns in the Shank3Q321R/Q321R
brain and reduced neuronal excitability in Shank3Q321R/Q321R
hippocampal CA1 neurons (Figure 3) suggest the possibility that
the Shank3Q321R/Q321R mutation disrupts the balance between
neuronal excitation and inhibition in the brain, a mechanism
suggested to underlie ASD (Rubenstein and Merzenich, 2003).
To test this, we assessed the susceptibility of Shank3Q321R/Q321R
mice to seizures induced by the GABAA receptor antagonist
pentylenetetrazole (PTZ).
We found that male Shank3Q321R/Q321R mice are less
susceptible to PTZ-induced seizures compared with WT mice,
as shown by the latency to seizure stage 1 (although not
stage 2), latency-based seizure susceptibility index, and final
seizure stages reached (Figure 10). Spontaneous behavioral
seizures were not observed in the absence of PTZ injection.
These results collectively suggest that the homozygous Shank3
Q321R mutation induces abnormal EEG patterns and decreased
PTZ-induced seizure susceptibility in male mice.
DISCUSSION
Our results indicate that the Shank3 Q321R mutation, located in
exon 8 of the Shank3 gene encoding the C-terminal part of the
ARR domain of the protein, leads to substantial destabilization
of the ARR-containing Shank3a protein variant and synaptic,
behavioral, and EEG/seizure abnormalities in mice.
Our in vivo data from Shank3Q321R/Q321R mice indicate that
the Q321R mutation induces a substantial decrease (∼18% of
WT levels) in the total level of the ARR-containing Shank3a
protein variant in the Shank3Q321R/Q321R brain (Figure 2F).
In addition, our molecular modeling analyses suggest that the
Q321R mutation is less likely to affect the intramolecular SPN-
ARR interaction but more likely to affect the protein stability
or intermolecular interactions of Shank3. The ARR domain of
Shank3 is known to interact with Sharpin and α-fodrin (Bockers
et al., 2001; Lim et al., 2001), and the Q321R mutation has
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FIGURE 8 | Normal object-recognition and fear memory in homozygous male Shank3Q321R/Q321R mice. (A) Normal levels of object recognition memory in
Shank3Q321R/Q321R mice (2–4 months; male) in the novel object recognition test, as shown by the discrimination index over a familiar object and a novel object (see
Materials and Methods for details) presented 24 h after exploring two identical objects on the first day. n = 11 mice (WT), 13 mice (Q321R), ns, not significant,
Student’s t-test. (B) Normal acquisition, retrieval, and extinction of contextual fear memory Shank3Q321R/Q321R mice (3–6 months; male), as shown by freezing levels.
Mice were given 5 foot shocks (2-min intervals) during the 12-min fear memory acquisition phase (day 1), and were consecutively exposed to the same context 24 h
after the training (day 2) and also during days 3–9 for fear extinction. n = 13 mice (WT), 17 mice (Q321R), repeated measures two-way ANOVA. (C) Normal
somatosensory function in Shank3Q321R/Q321R mice (6 months; male) in the hot plate test, as shown by latency to first licking/jumping. n = 17 mice (WT) and 20
mice (Q321R), ns, not significant, Student’s t-test (for latency to first licking), and Mann–Whitney U-test (for latency to first jumping). (D) Normal somatosensory
function in Shank3Q321R/Q321R mice (2 months; male) in the von Frey test, as shown by threshold for response to stimulation. n = 10 mice (WT) and 11 mice
(Q321R), ns, not significant, Mann–Whitney U-test.
been shown to enhance Shank3 binding to Sharpin but not
α-fodrin (Mameza et al., 2013). Given that Shank proteins can
be ubiquitinated and deubiquitinated in an activity-dependent
manner to regulate excitatory synapse structure and function
(Ehlers, 2003; Kerrisk Campbell and Sheng, 2018) and that
Sharpin is a component of the E3 ligase complex termed LUBAC
(linear ubiquitin chain assembly complex) (Ikeda et al., 2011;
Tokunaga et al., 2011; Iwai et al., 2014; Hrdinka and Gyrd-
Hansen, 2017), it is tempting to speculate that the strong decrease
in the levels of the mutant Shank3 protein (Q321R) might involve
enhanced protein ubiquitination. Dissimilar to the results from
Shank3Q321R/Q321R mice, however, Shank3+/Q321R mice show
normal levels of Shank3 proteins, as compared with WT mice
(Figure 2F). Therefore, distinct pathophysiological mechanisms
of the Shank3 Q321R mutation at the protein level (i.e.,
decreased protein levels vs. abnormal protein function) might
lead to similar behavioral abnormalities in Shank3Q321R/Q321R
and Shank3+/Q321R mice, likely by acting on similar sets of
neurons in the brain.
Electrophysiologically, there were no changes in the frequency
or amplitude of mEPSCs in male Shank3Q321R/Q321R CA1
pyramidal or dorsolateral striatal neurons (Figure 3; summarized
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FIGURE 9 | Abnormal EEG patterns in Shank3Q321R/Q321R mice. (A,B) Abnormal EEG patterns in frontal and parietal lobes of the Shank3Q321R/Q321R brain
(3 months; male). EEG power was calculated by combining data from both left and right hemispheres in the frontal or parietal lobe. Note that the EEG power in the
delta frequency range is decreased, whereas that in the alpha frequency range is increased. The vertical dotted lines in the power spectral density (PSD) diagrams
indicate the boundaries between different frequency ranges (delta, 0–4 Hz; theta, 4–12 Hz; alpha, 12–30 Hz; low gamma, 30–80 Hz; high gamma, 80–130 Hz).
n = 10 mice (WT) and 10 mice (Q321R) for frontal lobe and 9 mice (WT) and 10 mice (Q321R) for parietal lobe, ∗P < 0.05, ns, not significant, Student’s t-test,
Mann–Whitney U-test, Welch’s t-test.
in Table 1). These results suggest that homozygous deletion
of ARR-containing Shank3 protein variants does not affect
mEPSCs in hippocampal or striatal neurons. Potential reasons
for these results could be that ARR-containing Shank3 protein
variants only minimally affect excitatory synapse development
and function in hippocampal and striatal neurons or that some
compensatory changes have occurred. Similar to our results,
mEPSC frequency and amplitude are unchanged in Shank3
mouse lines carrying similar ARR deletions, including Shank319
mice (lacking exon 9) (Lee et al., 2015) and Shank314−9 mice
(lacking exons 4–9) (Wang et al., 2011; Jaramillo et al., 2016).
Notably, however, heterozygous deletion of Shank3 exons 4–9 in
mice induces an increase in mEPSC frequency and a decrease
in mEPSC amplitude (Bozdagi et al., 2010), suggesting different
effects of homozygous and heterozygous deletions.
Whereas mEPSCs and mIPSCs were unchanged in male
Shank3Q321R/Q321R CA1 pyramidal neurons, and mEPSCs
were unchanged in female Shank3Q321R/Q321R CA1 pyramidal
neurons, the frequency but not amplitude of mIPSCs was
increased in female CA1 neurons (Figure 3 and Supplementary
Figures 1A,B). These changes may involve some presynaptic
changes given that Shank3 proteins are mainly localized at
excitatory postsynaptic sites. Alternatively, the Shank3 protein
with Q321R mutation might be localized at subcellular
sites other than excitatory postsynaptic sites or even at
inhibitory postsynaptic sites in CA1 pyramidal neurons,
although our Shank3 antibodies were not good enough for
immunohistochemical analyses at the electron microscopic level.
Intriguingly, a similar increase in mIPSC frequency has been
reported in Shank319 CA1 pyramidal neurons (Lee et al.,
2015), although mIPSCs were not affected in Shank314−9 CA1
pyramidal neurons (Wang et al., 2011).
Our data indicate a decrease in neuronal excitability in
male Shank3Q321R/Q321R CA1 pyramidal neurons, a conclusion
supported by the current-firing curve (Figure 3). However,
there were no changes in the current-voltage relationship, input
resistance, or Sag ratio. These results suggest potential changes
in the threshold or properties of action potentials involving
sodium or potassium channels, rather than changes in resting
conductance involving HCN (hyperpolarization-activated cyclic
nucleotide–gated) channels. Notably, a previous study has
reported that cultured hippocampal neurons obtained from
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FIGURE 10 | Decreased susceptibility to PTZ-induced seizures in
Shank3Q321R/Q321R mice. (A) Percentage of animals that can reach stage 1
(behavioral arrest) seizures. Seizures were induced in WT and
Shank3Q321R/Q321R mice (3–4 months; male) by intraperitoneal injection of
PTZ (50 mg/kg). n = 10 mice (WT), 13 mice (Q321R), ∗∗P < 0.01, log-rank
(Mantel-Cox) test (p = 0.0047). (B) Latency to reach stage 1 (behavioral arrest)
seizures. ∗P < 0.05, Mann–Whitney U-test. (C) Percentage of animals that
can reach stage 2 (myoclonic) seizures. ns, not significant, log-rank
(Mantel-Cox) test (p = 0.1881). (D) Latency to reach stage 2 (myoclonic)
seizures. ns, not significant, Mann–Whitney U-test. (E) Seizure susceptibility
based on the latencies to reach stage 1, 2, or 3 seizure (see Materials and
Methods for details on the definition of seizure susceptibility). ∗∗P < 0.01,
Student’s t-test. (F) Duration of seizure stages 1, 2, and 3. ∗∗P < 0.01,
∗∗∗P < 0.001, ns, not significant, one-way ANOVA with
Kruskal–Wallis/Holm–Sidak test (within-genotype stage 1/2/3 comparison)
and Mann–Whitney U-test (between-genotype stage 1/2/3 comparison).
(G) Final seizure stages that animals reached, expressed as a percentage of
animals. ∗P < 0.05, Chi-square test.
Shank3 mice carrying heterozygous and homozygous deletion
of exons 13–16 encoding the PDZ domain of Shank3 (Peca
et al., 2011) display markedly increased neuronal excitability
in association with increased input resistance and decreased
hyperpolarization-activated currents (Ih). Moreover, human
neurons with a SHANK3 exon 13 deletion display similar changes
(Yi et al., 2016). This difference may be attributable to differences
in the specific exons of the Shank3 gene affected: exon 8 in our
study of the Q321R mutation and exons 13–16 in these previous
studies. The former encompasses mainly ARR-containing
Shank3 protein variants, whereas the latter encompasses almost
all Shank3 protein variants. Although further details remain
to be elucidated, our electrophysiology results suggest that,
at minimum, the decreased neuronal excitability and increased
mIPSC frequency in Shank3Q321R/Q321R CA1 pyramidal
neurons would substantially suppress the output functions
of these neurons.
Behaviorally, heterozygous Shank3+/Q321R mice show
moderately enhanced social communication and self-grooming
and moderate anxiolytic-like behaviors in the light-dark tests
(although open-field center activity and EPM performance were
normal), while showing normal levels of locomotor activity and
three-chamber social interaction (Figures 4, 5). Homozygous
Shank3Q321R/Q321R mice show behaviors that are largely similar
to those in heterozygous Shank3+/Q321R mice, displaying
moderately enhanced self-grooming, moderate anxiolytic-like
behaviors in EPM and light-dark tests (although open-field
center activity was normal), while showing normal levels of
locomotor activity, social interaction (three-chamber and direct
social interaction), social communication (courtship USV), and
object–recognition and contextual fear memory (Figures 6–8;
summarized in Table 1).
Notably, Shank319 mice, which carry a similar alteration in
the ARR domain, show behaviors that are largely similar to
those of Shank3Q321R/Q321R mice, displaying normal levels of
locomotor activity, anxiety-like behavior (open-field center time),
social interaction and communication (three-chamber and pup
USV), and object–recognition memory, although self-grooming
was also normal in these mice (Lee et al., 2015). Behavioral
impacts in other ARR-deletion–carrying mouse lines are more
severe compared with those reported here, a difference that is
likely attributable to larger deletions in the ARR domain of
the Shank3 protein. Specifically, self-grooming is enhanced in
Shank314−9 mice, similar to our mice, but these former mice
additionally show altered social interaction and communication
and impaired novel object–recognition memory (Bozdagi et al.,
2010; Wang et al., 2011; Yang et al., 2012; Jaramillo et al.,
2016; Dhamne et al., 2017). In addition, Shank314−7 mice show
abnormal social novelty recognition, but normal self-grooming
(Peca et al., 2011), again different from our mice.
Identifying synaptic mechanisms and neural circuits
associated with the behavioral phenotypes in Shank3Q321R
mice will require additional investigation. Notably, however,
while male Shank3Q321R/Q321R mice show normal mEPSCs
and mIPSCs in the hippocampus and anxiolytic-like behavior,
enhanced self-grooming, and suppressed digging, female
Shank3Q321R/Q321R mice show increased mIPSC frequency in the
Frontiers in Molecular Neuroscience | www.frontiersin.org 17 June 2019 | Volume 12 | Article 155
fnmol-12-00155 June 14, 2019 Time: 17:28 # 18
Yoo et al. Abnormal Phenotypes in Shank3-Q321R-Mutant Mice




mEPSC Frequency -, amplitude -




mEPSC Frequency -, amplitude -
mIPSC Frequency -, amplitude -
Behavior




Adult courtship USV –
Repetitive behavior Self-grooming (Laboras cage) –
Self-grooming (novel home cage) ↑
Digging (novel home cage) ↓
Locomotor activity Laboras –
Open-field –
Anxiety-like behavior Open field center time –
Elevated plus-maze (open-arm time) ↓
Light/dark box (light-chamber time) ↓
Learning and memory Novel object recognition –
Contextual fear conditioning,
retrieval, and extinction
Acquisition (day 1) -
24-h retrieval (day 2) -
Extinction (days 3–9) -
Brain function EEG Baseline EEG Frontal-delta ↓
Parietal-alpha ↑
Left-right asymmetry
Seizure Susceptibility to PTZ-induced seizure ↓
Up and down arrows, increases and decreases, respectively; −, no significant change. Male mice were used to obtain the results listed in the table. Additional
measurements for select electrophysiological and behavioral parameters were also made in females and described in Results but not summarized in this table.
hippocampus and normal anxiety-like behavior, self-grooming,
and digging (Figures 3, 6, 7 and Supplementary Figures 1C–F).
Therefore, the increased mIPSC frequency in female mice might
represent a part of the compensatory changes that might have
normalized the anxiety-like behaviors and repetitive behaviors in
female Shank3Q321R/Q321R mice.
In addition, the most strongly affected Shank3 protein variant
in our mice was Shank3a, which is abundantly expressed in
the striatum among many brain regions (Wang et al., 2014). In
addition, the striatopallidal pathway has been shown to regulate
self-grooming in Shank3113−16 mice (Wang et al., 2017). In
addition, the striatum has emerged as one of the key brain regions
involved in the regulation of anxiety-like behaviors, in addition to
the amygdala, bed nucleus of the stria terminalis, hippocampus,
and ventromedial prefrontal cortex (Lago et al., 2017). Therefore,
it is tempting to speculate that striatal dysfunctions might
contribute to the self-grooming and anxiolytic-like behavior
in Shank3Q321R mice. Although male Shank3Q321R/Q321R mice
displayed normal levels of excitatory and inhibitory spontaneous
synaptic transmission (mEPSCs and mIPSCs) in the dorsolateral
striatum (Figures 3G,H), additional investigations might reveal
some other striatal dysfunctions in synaptic transmission and
plasticity. For instance, previous studies have reported decreased
NMDA/AMPA ratio but normal mEPSCs and mIPSCs in the
dorsal striatum of homozygous and heterozygous Shank314−9
mice (Jaramillo et al., 2016).
Shank3Q321R/Q321R mice (males) display abnormal baseline
EEG patterns, with a decreased delta band in the frontal lobe
and increased alpha band in the parietal lobe (Figure 9). In
addition, we found left-right asymmetry in the parietal, but
not frontal, lobe of the Shank3Q321R brain. Understanding the
biological significances of these results would have to involve,
for instance, additional analyses of sleep behaviors and rhythms
in Shank3Q321R/Q321R mice and acquisition of EEG- and sleep-
related details from the individual carrying the Q321R mutation
(Moessner et al., 2007). Nonetheless, our data are in line with
the previous studies in ASD that have reported abnormalities
in the power, coherence, and asymmetry of EEGs in the delta
and alpha ranges in addition to other frequency ranges (Wang
et al., 2013). Moreover, the individual carrying the SHANK3
Q321R mutation was shown to display abnormal EEG patterns
(Moessner et al., 2007), although it is unclear whether the
abnormal EEGs were observed in similar frequency ranges.
Notably, a previous study on Shank3113−16 mice reported
abnormally enhanced EEGs in the low gamma range (30–80 Hz),
known to be associated with parvalbumin-positive GABAergic
neurons (Sohal et al., 2009), but normal EEGs in other frequency
ranges (Dhamne et al., 2017). This difference could again reflect
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differences in the exons deleted in the two mutant mouse lines,
with Shank3113−16 mice lacking a larger number of Shank3
splice variants.
Our Shank3Q321R/Q321R mice (males) are more resistant
to PTZ-induced seizures and do not display spontaneous
behavioral seizures (Figure 10). These results are in line
with the suppressed excitability of CA1 pyramidal neurons
in these animals. Similar to our results, a previous study
on Shank3113−16 mice revealed a decrease in susceptibility
to PTZ-induced seizures (Dhamne et al., 2017) and lack of
spontaneous behavioral seizures (Peca et al., 2011). In addition,
Shank314−22 mice show tonic hyperactivity in the cortico-
striatal-thalamic axis, revealed by multi-site in vivo recordings,
but do not show spontaneous behavioral seizures (Wang et al.,
2016). In contrast, a transgenic mouse line carrying duplicated
Shank3 shows enhanced epileptiform spikes in the dentate gyrus
and electrographic seizures (Han et al., 2013). These results
collectively suggest that Shank3 is an important regulator of
excitatory drive in the brain. Perhaps more importantly, the
individual with the Q321R mutation was shown to display
bilateral epileptiform discharges without seizures, in addition to
abnormal EEG patterns (Moessner et al., 2007). Therefore, the
EEG and seizure phenotypes of our Shank3Q321R mice may serve
as potential biomarkers for future studies.
CONCLUSION
Our data suggest that the Shank3 Q321R mutation in mice has
significant influences on Shank3 protein stability, hippocampal
neuronal excitability, anxiety-like and repetitive behaviors, EEG,
and seizure susceptibility.
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FIGURE S1 | Female Shank3Q321R/Q321R mice show increased mIPSC frequency
in CA1 pyramidal neurons but normal anxiety-like and repetitive behaviors. (A)
Normal mEPSCs in CA1 pyramidal neurons in the hippocampus of female
Shank3Q321R/Q321R mice (P21–27). The indicated values represent means ± SEM.
n = 14 neurons from 4 mice (WT; female) and 15 neurons from 4 mice (Q321R),
ns, not significant, Mann–Whitney U-test (for frequency) and Student’s t-test (for
amplitude). (B) Increased frequency, but normal amplitude, of mIPSCs in CA1
pyramidal neurons in the hippocampus of female Shank3Q321R/Q321R mice
(P22–26). n = 12 neurons from 4 mice (WT) and 13 neurons from 4 mice (Q321R),
∗P < 0.05, ns, not significant, Student’s t-test. (C) Normal anxiety-like behavior in
female Shank3Q321R/Q321R mice (3–5 months) in the elevated plus-maze test, as
shown by time spent in open arms of the maze. n = 9 mice (WT) and 12 mice
(Q321R), ns, not significant, Mann–Whitney U-test. (D) Normal anxiety-like
behavior in female Shank3Q321R/Q321R mice (3–5 months) in the light-dark test, as
shown by time spent in light chamber of the light-dark apparatus. n = 9 mice (WT)
and 12 mice (Q321R), ns, not significant, Mann–Whitney U-test. (E) Normal
self-grooming in female Shank3Q321R/Q321R mice (3–5 months) in home cages
with bedding (10 min), as shown by total self-grooming time. n = 9 mice (WT) and
11 mice (Q321R), ns, not significant, Welch’s t-test. (F) Normal digging in female
Shank3Q321R/Q321R mice (3–5 months) in home cages with bedding (10 min), as
shown by total digging time. n = 9 mice (WT) and 11 mice (Q321R), ns, not
significant, Student’s t-test.
FIGURE S2 | Shank3Q321R/Q321R mice show normal self-grooming in novel home
cages without light, Laboras cages with light, and open-field arena with light. (A)
Normal self-grooming in Shank3Q321R/Q321R mice (4–5 months; male) in novel
home cages without light (0 lux; 10 min). n = 16 mice (WT), 20 mice (Q321R), ns,
not significant, Mann–Whitney U-test. (B) Normal self-grooming in
Shank3Q321R/Q321R mice (4–5 months; male) in Laboras cages (a novel
environment) with light (∼50 lux; 10 min). n = 9 mice (WT), 8 mice (Q321R), ns, not
significant, Mann–Whitney U-test. (C) Normal self-grooming in Shank3Q321R/Q321R
mice (2–3 months; male) in an open-field arena (a novel environment) with light
(∼100 lux; 10 min). n = 13 mice (WT), 14 mice (Q321R), ns, not significant,
Student’s t-test.
FIGURE S3 | Abnormal EEG patterns in the left and right hemispheres in
Shank3Q321R/Q321R mice. (A,B) Altered left and right hemispheric EEG powers in
the frontal and parietal lobes of the Shank3Q321R/Q321R brain (3 months; male).
Note that the frontal lobe displays decreased delta power in both left and right
hemispheres, whereas the parietal lobe displays decreased delta power and
increased theta and alpha powers only in the right hemisphere. n = 10 mice (WT)
and 10 mice (Q321R) for frontal lobe and 9 mice (WT) and 10 mice (Q321R) for
parietal lobe, ∗P < 0.05, ∗∗P < 0.01, ns, not significant, Student’s t-test,
Mann–Whitney U-test, Welch’s t-test.
TABLE S1 | Statistical details.
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